✦ LIBER ✦

Updated Results of a Phase III Trial Comparing Ibritumomab Tiuxetan with Rituximab in Previously Treated Patients with Non-Hodgkin's Lymphoma

✍ Scribed by Gibson, Angelia D.; Longo, Dan L.; Jain, Vinay K.

Book ID: 119615191
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 91 KB
Volume: 3
Category: Article
ISSN: 1526-9655
DOI: 10.1016/s1526-9655(11)70259-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enteroviral meningoencephalitis in a pat

Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab

✍ B. P. PADATE; J. KEIDAN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Fludarabine and mitoxantrone followed by

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)

✍ Pier Luigi Zinzani; Monica Tani; Alessandro Pulsoni; Marco Gobbi; Alessio Perott 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 119 KB

Radiation Dosimetry Results From a Phase

Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

✍ Wiseman, Gregory A.; Leigh, Bryan R.; Erwin, William D.; Sparks, Richard B.; Pod 📂 Article 📅 2003 🏛 Mary Ann Liebert 🌐 English ⚖ 374 KB

Treatment with yttrium 90 ibritumomab ti

Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma

✍ Emmanouilides, Christos; Witzig, Thomas E.; Gordon, Leo I.; Vo, Katie; Wiseman, 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 352 KB

A phase 2 trial of fludarabine and mitox

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

✍ Pier Luigi Zinzani; Monica Tani; Stefano Fanti; Vittorio Stefoni; Gerardo Musura 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Abstract ## BACKGROUND A prospective, single‐arm, open‐label, nonrandomized Phase 2 study of combined fludarabine and mitoxantrone (FM) plus radioimmunotherapy was conducted to evaluate efficacy and safety in patients with untreated, indolent, nonfollicular non‐Hodgkin lymphoma (NHL). ## METHO

Use of Ibritumomab Tiuxetan Anti-CD20 Ra

Use of Ibritumomab Tiuxetan Anti-CD20 Radioimmunotherapy in a Non-Hodgkin's Lymphoma Patient Previously Treated with a Yttrium-90–Labeled Anti-CD22 Monoclonal Antibody

✍ Tsai, Donald E.; Maillard, Ivan; Schuster, Stephen J.; Nasta, Sunita D.; Porter, 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 478 KB